How to Control Impurities during API drug manufacturing

by | Feb 19, 2018 | API Manufacturing, Impurities, Video

Dr. Rajesh Shukla, Vice President Research and Development at Seqens Talks about Controlling Impurities during API drug manufacturing.

Related posts:

Want to know why early drug development costs so much?
Cryogenic API Manufacturing
Christophe Eychenne-baron, R&D Center Grand Opening Devens Massachusetts
How to Stem the Flow of Tainted Generic Drugs and Product Recalls
7 things to look for in a CMO’S CGMP Manufacturing Capabilities